Please wait while we open this resource.
K
Clinical reviews
DE-ESCALATION OF ANTIPLATELET THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: TIME TO CHANGE OUR STRATEGY?
Institute
PDF9 pages1.9 MB
Dual antiplatelet therapy (DAPT) is the standard treatment following acute coronary syndromes (ACS) or chronic coronary syndromes (CCS) that undergo percutaneous coronary intervention (PCI). The article emphasizes the need for individualized approaches to optimize antithrombotic strategies, especially for patients at high bleeding risk. It reviews current evidence supporting the implementation of de-escalation strategies in clinical practice, aiming to enhance patient outcomes by minimizing complications.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology